Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000046
Filing Date
2024-05-09
Accepted
2024-05-09 06:08:17
Documents
13
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-5_050924.htm 6-K 11813
2 EX-99.1 stock-compensation_plan.htm EX-99.1 34307
3 GRAPHIC stock-compensation_plan001.jpg GRAPHIC 232454
4 GRAPHIC stock-compensation_plan002.jpg GRAPHIC 222314
5 GRAPHIC stock-compensation_plan003.jpg GRAPHIC 238134
6 GRAPHIC stock-compensation_plan004.jpg GRAPHIC 206026
7 GRAPHIC stock-compensation_plan005.jpg GRAPHIC 240102
8 GRAPHIC stock-compensation_plan006.jpg GRAPHIC 126816
9 GRAPHIC stock-compensation_plan007.jpg GRAPHIC 188091
10 GRAPHIC stock-compensation_plan008.jpg GRAPHIC 36010
11 GRAPHIC stock-compensation_plan009.jpg GRAPHIC 180372
12 GRAPHIC stock-compensation_plan010.jpg GRAPHIC 250137
13 GRAPHIC stock-compensation_plan011.jpg GRAPHIC 36979
  Complete submission text file 0001395064-24-000046.txt   2744201
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 24928363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)